Lazarini Mariana, Bordeaux-Rego Pedro, Giardini-Rosa Renata, Duarte Adriana S S, Baratti Mariana Ozello, Zorzi Alessandro Rozim, de Miranda João Batista, Lenz Cesar Carlos, Luzo Ângela, Olalla Saad Sara Teresinha
1 Hematology and Blood Transfusion Center, University of Campinas. National Institute of Blood Technology and Science, Campinas, São Paulo, Brazil.
2 Department of Biological Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil.
Cartilage. 2017 Oct;8(4):439-443. doi: 10.1177/1947603516675914. Epub 2016 Nov 29.
Objective Articular cartilage is an avascular tissue with limited ability of self-regeneration and the current clinical treatments have restricted capacity to restore damages induced by trauma or diseases. Therefore, new techniques are being tested for cartilage repair, using scaffolds and/or stem cells. Although type II collagen hydrogel, fibrin sealant, and adipose-derived stem cells (ASCs) represent suitable alternatives for cartilage formation, their combination has not yet been investigated in vivo for focal articular cartilage defects. We performed a simple experimental procedure using the combination of these 3 compounds on cartilage lesions of rabbit knees. Design The hydrogel was developed in house and was first tested in vitro for chondrogenic differentiation. Next, implants were performed in chondral defects with or without ASCs and the degree of regeneration was macroscopically and microscopically evaluated. Results Production of proteoglycans and the increased expression of collagen type II (COL2α1), aggrecan (ACAN), and sex-determining region Y-box 9 (SOX9) confirmed the chondrogenic character of ASCs in the hydrogel in vitro. Importantly, the addition of ASC induced a higher overall repair of the chondral lesions and a better cellular organization and collagen fiber alignment compared with the same treatment without ASCs. This regenerating tissue also presented the expression of cartilage glycosaminoglycan and type II collagen. Conclusions Our results indicate that the combination of the 3 compounds is effective for articular cartilage repair and may be of future clinical interest.
目的 关节软骨是一种无血管组织,自我再生能力有限,目前的临床治疗修复创伤或疾病所致损伤的能力也很有限。因此,正在测试使用支架和/或干细胞进行软骨修复的新技术。尽管II型胶原蛋白水凝胶、纤维蛋白密封剂和脂肪来源干细胞(ASC)是软骨形成的合适替代物,但它们的组合尚未在体内用于局灶性关节软骨缺损的研究。我们在兔膝关节软骨损伤处使用这三种化合物的组合进行了一个简单的实验程序。
设计 水凝胶在实验室自行研制,首先在体外进行软骨形成分化测试。接下来,在有或没有ASC的软骨缺损处进行植入,并从宏观和微观上评估再生程度。
结果 蛋白聚糖的产生以及II型胶原蛋白(COL2α1)、聚集蛋白聚糖(ACAN)和性别决定区Y盒9(SOX9)表达的增加证实了体外水凝胶中ASC的软骨形成特性。重要的是,与没有ASC的相同治疗相比,添加ASC可诱导软骨损伤的整体修复更好,细胞组织和胶原纤维排列更佳。这种再生组织还呈现出软骨糖胺聚糖和II型胶原蛋白的表达。
结论 我们的结果表明,这三种化合物的组合对关节软骨修复有效,可能具有未来临床应用价值。